Tuesday, April 18, 2006

PharmaFrontiers takes on private placement to spur reverse stock ...

PharmaFrontiers takes on private placement to spur reverse stock ...
Houston Business Journal - Houston,TX,USA
... PharmaFrontiers intends to use the proceeds to fund its Phase IIb trial with Tovaxin for the treatment of multiple sclerosis, which is scheduled to begin this ...

0 Comments:

Post a Comment

<< Home